Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model
AUTOR(ES)
Callejas, G.H., Figueira, R.L., Gonçalves, F.L.L., Volpe, F.A.P., Zuardi, A.W., Crippa, J.A., Hallak, J.E., Sbragia, L.
FONTE
Braz J Med Biol Res
DATA DE PUBLICAÇÃO
15/03/2018
RESUMO
Gastroschisis (GS) is an abdominal wall defect that results in histological and morphological changes leading to intestinal motility perturbation and impaired absorption of nutrients. Due to its anti-inflammatory, antioxidant, and neuroprotective effects, cannabidiol (CBD) has been used as a therapeutic agent in many diseases. Our aim was to test the effect of maternal CBD in the intestine of an experimental model of GS. Pregnant rats were treated over 3 days with CBD (30 mg/kg) after the surgical induction of GS (day 18.5 of gestation) and compared to controls. Fetuses were divided into 4 groups: 1) control (C); 2) C+CBD (CCBD); 3) gastroschisis (G), and 4) G+CBD (GCBD). On day 21.5 of gestation, the fetuses were harvested and evaluated for: a) body weight (BW), intestinal weight (IW), and IW/BW ratio; b) histometric analysis of the intestinal wall; c) immunohistochemically analysis of inflammation (iNOS) and nitrite/nitrate level. BW: GCBD was lower than CCBD (P<0.005), IW and IW/BW ratio: GCBD was smaller than G (P<0.005), GCBD presented lower thickness in all parameters compared to G (P<0.005), iNOS and nitrite/nitrate were lower concentration in GCBD than to G (P<0.005). Maternal use of CBD had a beneficial effect on the intestinal loops of GS with decreased nitrite/nitrate and iNOS expression.
Documentos Relacionados
- A comparison of an effect of different anti-inflammatory drugs on human platelets
- Effect of anti-inflammatory agents on serum gastrin concentrations.
- Ultrasound has no anti-inflammatory effect.
- An evaluation of the anti-inflammatory effect of flurbiprofen after cataract extraction.
- A proinflammatory cytokine interleukin-32β promotes the production of an anti-inflammatory cytokine interleukin-10